NEW YORK (GenomeWeb) – 908 Devices today announced that it has raised an additional $1.4 million as part of a Series C round of financing, bringing the total raised in the round to $13 million.

The latest fundraising included investments from Casdin Capital, as well as Ortho Clinical Diagnostics Chairman and CEO Martin Madaus and former Thermo Fisher Scientific Chairman Paul Meister, among others.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.